William C. Wirshing, MD

Case Report

Opioid Withdrawal Syndrome Following Naloxone Challenge

September 17, 2020

This report describes a case of opioid withdrawal syndrome following naloxone challenge in a patient receiving extended-release naltrexone.

Original Research

Clozapine and Risperidone in Moderately Refractory Schizophrenia: A 6-Month Randomized Double-Blind Comparison

May 25, 2016

Original Research

A Randomized, Double-Blind, Placebo-Controlled Trial of Modafinil for Negative Symptoms in Schizophrenia

May 15, 2007

Original Research

The Effects of Novel Antipsychotics on Glucose and Lipid Levels

October 1, 2002

Original Research

Clinical Predictors of Response to Clozapine Treatment in Ambulatory Patients With Schizophrenia

May 12, 2002

Letter to the Editor

Sleep Apnea Associated With Antipsychotic-Induced Obesity

April 1, 2002

Letter to the Editor

Delusions Associated With Quetiapine-Related Weight Redistribution

March 1, 2002

Article

Movement Disorders Associated With Neuroleptic Treatment

January 7, 2001

Article

Scales to Assess Efficacy and Safety of Pharmacologic Agents in the Treatment of Behavioral and Psychological Symptoms of Dementia

January 7, 2001

Original Research

Novel Antipsychotics: Comparison of Weight Gain Liabilities

June 30, 1999

Original Research

Predictive Value of Eosinophilia for Neutropenia During Clozapine Treatment

December 15, 1996